HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Viral Conjunctivitis

Subscribe to New Research on Viral Conjunctivitis

Inflammation, often mild, of the conjunctiva caused by a variety of viral agents. Conjunctival involvement may be part of a systemic infection.

Also Known As:

Conjunctivitis, Viral; Conjunctivitides, Viral; Viral Conjunctivitides

Networked: 17 relevant articles (1 outcomes, 4 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1.	Bacterial Conjunctivitis
2.	Cystitis
3.	Ophthalmia Neonatorum
4.	Corneal Opacity

Experts

1.	Zacchia, Rafael Santos: 1 article (09/2015)
2.	Abe, Ricardo Yuji: 1 article (09/2015)
3.	Pinto, Roberto Damian Pacheco: 1 article (09/2015)
4.	Lira, Rodrigo Pessoa Cavalcanti: 1 article (09/2015)
5.	Pereira, Andre Venancio Fernandes: 1 article (09/2015)
6.	Felix, João Paulo Fernandes: 1 article (09/2015)
7.	Bonon, Sandra Helena Alves: 1 article (09/2015)
8.	Arieta, Carlos Eduardo Leite: 1 article (09/2015)
9.	de Castro, Rosane Silvestre: 1 article (09/2015)
10.	Schutten, Martin: 1 article (03/2015)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Viral Conjunctivitis:

1.	Povidone-Iodine (Betadine)FDA LinkGeneric 01/01/1997 - "Although no commercial product for repeated application on the eye is currently available, PVP-I has been used in ophthalmology not only for pre- and postoperative antisepsis, but also for the treatment of bacterial and viral conjunctivitis and for prophylaxis against ophthalmia neonatorum. " 09/01/2015 - "To determine whether topical dexamethasone 0.1%/povidone-iodine 0.4% reduces the duration of presumed viral conjunctivitis better than artificial tears and whether the treatment relieves the symptoms of this disease. " 11/01/2002 - "Povidone-iodine 1.25% ophthalmic solution was as effective as neomycin-polymyxin B-gramicidin for treating bacterial conjunctivitis, somewhat more effective against chlamydia, and as ineffective against viral conjunctivitis. "
2.	Polymyxin B (Aerosporin)FDA LinkGeneric 11/01/2002 - "Povidone-iodine 1.25% ophthalmic solution was as effective as neomycin-polymyxin B-gramicidin for treating bacterial conjunctivitis, somewhat more effective against chlamydia, and as ineffective against viral conjunctivitis. "
3.	Neomycin FDA LinkGeneric 11/01/2002 - "Povidone-iodine 1.25% ophthalmic solution was as effective as neomycin-polymyxin B-gramicidin for treating bacterial conjunctivitis, somewhat more effective against chlamydia, and as ineffective against viral conjunctivitis. "
4.	Gramicidin (Gramicidin A)FDA LinkGeneric 11/01/2002 - "Povidone-iodine 1.25% ophthalmic solution was as effective as neomycin-polymyxin B-gramicidin for treating bacterial conjunctivitis, somewhat more effective against chlamydia, and as ineffective against viral conjunctivitis. "
5.	DNA (Deoxyribonucleic Acid)IBA 03/01/2015 - "Adenoviral DNA was detected by PCR in 213 of 488 (44%) of the ocular samples collected from patients with viral conjunctivitis during the 5-year study period. " 02/01/2008 - "The present study was carried out to explore the presence of Ad as a causative agent in clinically suspected viral conjunctivitis and to compare the performance of conventional virus isolation on cell cultures, direct detection of Ad antigens in conjunctival cells by a direct fluorescence assay, Ad DNA detection by polymerase chain reaction (PCR), and specific IgM measurement by ELISA. "
6.	Ophthalmic Solutions (Eye Drops)IBA 08/01/2000 - "A randomized, double-masked trial of topical ketorolac versus artificial tears for treatment of viral conjunctivitis." 04/01/2014 - "Our findings indicate that 0.45% ketorolac tromethamine was not superior to the use of artificial tears in relieving the signs and symptoms of viral conjunctivitis." 04/01/2014 - "Artificial tears alone versus 0.45% ketorolac tromethamine with artificial tears for the treatment of acute viral conjunctivitis." 08/01/2000 - "Topical ketorolac 0.5% used four times daily is no better than artificial tears at relieving the symptoms or signs of viral conjunctivitis and produces more stinging than artificial tears." 08/01/2000 - "To determine if topical ketorolac 0.5% relieves the symptoms and signs of viral conjunctivitis better than artificial tears. "
7.	KetorolacIBA 08/01/2000 - "A randomized, double-masked trial of topical ketorolac versus artificial tears for treatment of viral conjunctivitis." 08/01/2000 - "Topical ketorolac 0.5% used four times daily is no better than artificial tears at relieving the symptoms or signs of viral conjunctivitis and produces more stinging than artificial tears." 08/01/2000 - "To determine if topical ketorolac 0.5% relieves the symptoms and signs of viral conjunctivitis better than artificial tears. "
8.	Immunoglobulin M (IgM)IBA 02/01/2008 - "The present study was carried out to explore the presence of Ad as a causative agent in clinically suspected viral conjunctivitis and to compare the performance of conventional virus isolation on cell cultures, direct detection of Ad antigens in conjunctival cells by a direct fluorescence assay, Ad DNA detection by polymerase chain reaction (PCR), and specific IgM measurement by ELISA. "
9.	Antiviral Agents (Antivirals)IBA 02/12/2011 - "We systemically reviewed the literature to identify studies where antiviral drugs were used to treat viral conjunctivitis. " 02/12/2011 - "Treatment of viral conjunctivitis with antiviral drugs."
10.	AntigensIBA 02/01/2008 - "The present study was carried out to explore the presence of Ad as a causative agent in clinically suspected viral conjunctivitis and to compare the performance of conventional virus isolation on cell cultures, direct detection of Ad antigens in conjunctival cells by a direct fluorescence assay, Ad DNA detection by polymerase chain reaction (PCR), and specific IgM measurement by ELISA. "

Therapies and Procedures

1.	Excimer Lasers 01/01/1999 - "To report the recurrence of presumed post-viral conjunctivitis subepithelial corneal opacities after excimer laser phototherapeutic keratectomy (PTK). "
2.	Laser In Situ Keratomileusis (LASIK) 08/30/2008 - "Patients who have viral conjunctivitis after LASIK surgery should be examined carefully and managed with consideration of flap complications." 08/30/2008 - "Delayed epithelial ingrowth caused by viral conjunctivitis after LASIK."